Bipolar 1 Disorder Terminated Phase 4 Trials for Aripiprazole (DB01238)

IndicationStatusPhase
DBCOND0020745 (Bipolar 1 Disorder)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03643159A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive DisorderHealth Services Research